Tim V. D. H.
- Country
- The Netherlands
- Department
- Cardiology
Research Overview
- Evaluation of Aspirin Omission on Bleeding and Ischemic Outcomes in Non-ST-Segment Elevation Acute Coronary Syndrome Patients
- Evaluation of Bosentan in the Management of Coronary Vasospasm: A Randomized Controlled Trial
- Phase 2b Randomized Study of Encoberminogene Rezmadenovec in Refractory Angina Due to Coronary Artery Disease with Flurpiridaz F 18 and 13N-Ammonia
Data & Insights
Has run more than one trial at 6 of 50 partner sites.
Specializations
Coronary Vascular Disorders
The investigator specializes in studying coronary vasospasm and coronary vasomotor dysfunction, focusing on innovative therapeutic approaches for patients experiencing these conditions.
- Endothelin receptor antagonism treatment
- Epicardial vasospasm management
- Acetylcholine reactivity testing
Primary interest lies in evaluating novel therapeutic strategies for patients with persistent angina-like symptoms.
Acute Coronary Syndromes
The investigator conducts research in the treatment of non-ST segment elevation acute coronary syndrome, with particular attention to optimizing antithrombotic therapy regimens.
- Bleeding risk optimization
- Antithrombotic therapy
- Ischemic event prevention
Focus areas include the evaluation of modified antiplatelet strategies to enhance patient safety while maintaining therapeutic efficacy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.